BMS-P5 |
BMS-P5 |
1549811-36-0 |
(4S,5R)-(-)-4-METHYL-5-PHENYL-2-OXAZOLIDINONE |
(4S,5R)-(-)-4-甲基-5-苯基-2-恶唑啉酮 |
16251-45-9 |
FMoc-Val-Cit-PAB |
Fmoc-Val-Cit-PAB |
159858-22-7 |
6-(2,2,2-TRIFLUOROETHOXY)PYRIDINE-3-CARBONITRILE |
5-氰基-2-(2,2,2-三氟乙氧基)吡啶 |
159981-18-7 |
UNC0379 |
UNC0379 |
1620401-82-2 |
(S)-tert-butyl 2-((1R,2R)-3-(((1S,2R)-1-hydroxy-1-phenylpropan-2-yl)amino)-1-methoxy-2-methyl-3-oxopropyl)pyrrolidine-1-carboxylate |
BOC-DAP-NE |
160800-65-7 |
XY1 |
N-2-萘基-N'-[2-氧代-2-(1-吡咯烷基)乙基]脲 |
1624117-53-8 |
Protein degrader 1 (TFA) |
1631137-51-3 |
1631137-51-3 |
BAR 502 |
BAR 502 |
1612191-86-2 |
1H-Benzotriazole-7-carboxylic acid, 1-methyl-5-(2'-methyl[1,1'-biphenyl]-4-yl)- |
AG-636 |
1623416-31-8 |
Benzaldehyde,4,4'-[2-[4,5-bis(4-formylphenyl)-1,3-dithiol-2-ylidene]-1,3-dithiole-4,5-diyl]bis- |
四硫富瓦烯四苯甲醛 |
1639134-02-3 |
ASTX660 |
ASTX660 |
1799328-86-1 |
CA-4948 |
CA-4948 |
1801343-74-7 |
mi503 |
MI-503 |
1857417-13-0 |
N-{(1S,2R)-1-benzyl-3-[(3R,4S)-3,4-dihydroxypyrrolidin-1-yl]-2-hydroxy-3-oxopropyl}-5-chloro-1H-indole-2-carboxaMide|ingliforib |
CPD2802 |
186392-65-4 |
(3R,4S)-4-[4-(Benzyloxy)phenyl]-1-(4-fluorophenyl)-3-[3-(4-fluorophenyl)-3-oxopropyl]azetidin-2-one |
(3R,4S)-4-[4-(苄氧基)苯基]-1-(4-氟苯基)-3-[3-(4-氟苯基)-3-氧代丙基]氮杂环丁烷-2-酮 |
190595-65-4 |
AP20187 |
AP 20187 |
195514-80-8 |
Lazertinib |
YH-25448 |
1903008-80-9 |
Fmoc-Ala-Ala-Asn(Trt)-OH |
Fmoc-Ala-Ala-Asn(Trt)-OH |
1951424-92-2 |
Acetic acid, 2-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]oxy]-, 1,1-dimethylethyl ester |
2-((2-(2,6-二氧代哌啶-3-基)-1,3-二氧代异吲哚啉-4-基)氧基)乙酸叔丁酯 |
1950635-36-5 |